z.cardoso

TL2 · Dhaka

Contributes reviews on supplier material. Based in Dhaka.

Joined 28 April 2025 · last posted 2d

68 posts, newest first. Showing up to 150.

What a reversed-phase purity number actually is Replied, post #96 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 20 likes One caution on reversed-phase purity number: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…
What to bring: records that a clinician can actually use — a second dataset Replied, post #73 · Clinical › Prescriber conversations · 24 Jul 2026 · 16 likes This follows post #72 rather than contradicting it. A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Restarting after a long gap: what the labelling implies Replied, post #38 · Practice › Dosing & titration · 22 Jul 2026 · 0 likes Post #35 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #117 · Start Here › How to Ask · 11 Jul 2026 · 24 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #69 · Analytics › Home & field testing · 7 Jul 2026 · 6 likes Taking post #68 at face value and following it one step further. Colorimetric and lateral-flow methods generally respond to a class of chemistry rather than to a…
Here for the analytics and not much else Replied, post #2 · Lounge › Introductions · 6 Jul 2026 · 23 likes If you are arriving from somewhere louder, the pace here will feel slow. A topic can sit for two days and then get a reply that is worth the wait. That is the design…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #51 · Analytics › Impurities & related substances · 6 Jul 2026 · 4 likes Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute depends on the hydrophobicity of the residue that is missing, so…
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #8 · marked as the solution · Devices › Syringes & needles · 20 Jun 2026 · 7 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
Racemisation and why it is invisible to a mass measurement Replied, post #124 · Analytics › Impurities & related substances · 15 Jun 2026 · 20 likes The arithmetic on racemisation is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Transporting a vial for a weekend away — a second dataset Replied, post #78 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Since Transporting a vial keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
Research-use-only status: what it means legally and practically Replied, post #54 · Compounds › Other compounds · 7 Jun 2026 · 0 likes Adding a null result on research-use-only status. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
What changed in 2026, by region — does this still hold? Replied, post #10 · Access › International · 22 May 2026 · 26 likes Picking up post #9: that is the part I would want checked first. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical…
A site rotation scheme that is easy enough to actually follow Replied, post #66 · Practice › Administration · 18 May 2026 · 2 likes Post #62 describes the usual case. This is about the unusual one. Summarising the site rotation scheme thread so far, since it is long and the answer is buried: the…
Official shortage notices and what they authorise Replied, post #20 · Access › Shortages · 25 Apr 2026 · 18 likes Narrowing post #17, because the general version has more than one answer. Manufacturer allocation decisions during a shortage are commercial and are rarely explained,…
The "under review" status pill and when a moderator applies it Replied, post #91 · Evidence › Preprints · 23 Apr 2026 · 29 likes Everything in post #88 holds. The case it does not cover is the one I have. The most useful convention this subcategory has: state the status, state the version, state…
Sample handling between despatch and injection Replied, post #61 · Analytics › Method validation · 23 Apr 2026 · 16 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #150 · Access › Pricing · 18 Apr 2026 · 6 likes Worth separating two things that post #146 runs together. I would call the community position on Price changes likely rather than established, and I would be…
The "under review" status pill and when a moderator applies it Replied, post #74 · Evidence › Preprints · 15 Apr 2026 · 0 likes Adding the measurement that post #71 says would settle it. Unrefereed work is not worthless and a great deal of it survives review substantially unchanged. That is the…
Sample size intuition for a personal experiment — does this still hold? Replied, post #9 · Research Methods › Statistics · 20 Mar 2026 · 2 likes Effect size with an interval is more informative than a significance verdict in essentially every case discussed here. For what it is worth, the same held on the two…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #75 · Start Here › How to Ask · 18 Mar 2026 · 26 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
Reading an interaction checker output critically Replied, post #145 · Practice › Interactions · 13 Mar 2026 · 2 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 3 Mar 2026 · 18 likes Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be used together rather than instead of each other. Not…
[2026 update] Availability by country, dated, with primary sources Replied, post #31 · Access › International · 24 Feb 2026 · 22 likes That reframing is the whole thing. The facts I already had.
Pregnancy and pregnancy planning: contraindication and washout Replied, post #40 · Clinical › Special populations · 12 Feb 2026 · 27 likes Building on post #38 rather than restating it. Pregnancy and pregnancy planning: I have looked for the primary source twice and failed twice. Either it does not exist…
Whether protein timing matters at a large deficit Replied, post #22 · Nutrition & Training › Protein & intake · 3 Feb 2026 · 3 likes Thank you — that answers what I came here to find out.
Heterogeneity as information rather than as a nuisance Replied, post #88 · Evidence › Meta-analyses · 3 Feb 2026 · 16 likes Answering the question post #86 raises rather than the one it answers. Something worth flagging about heterogeneity: the strongest-sounding claims in this thread are…
Sulfonylureas: the interaction most worth taking seriously Replied, post #2 · Practice › Interactions · 28 Jan 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
Muscle cramps: the ordinary causes before the exotic ones Replied, post #48 · Practice › Side effects · 17 Jan 2026 · 1 like The arithmetic in post #47 is right; the assumption feeding it is the part to check. Reading this muscle cramps thread as someone who came in with a fixed view: the…
Second pass at: Fasting versus non-fasting and which tests care Replied, post #6 · Clinical › Bloodwork · 5 Jan 2026 · 19 likes Post #5 and I disagree about the size of the effect, not about the direction. A trend needs at least three points to be a trend. Two points are a line and a line…
Documentation that appears only after payment Replied, post #121 · Sourcing › Red flags · 29 Dec 2025 · 9 likes Adding a null result on documentation. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Why oral semaglutide needs an absorption enhancer at all Replied, post #54 · Compounds › Oral incretins · 29 Nov 2025 · 0 likes Post #53 and I disagree about the size of the effect, not about the direction. Two claims get bundled together under oral semaglutide and they need separating. The…
Specification in the result column: why that is a meaningful error Replied, post #78 · Analytics › COA interpretation · 24 Nov 2025 · 0 likes Post #75 is the version of this I will quote in future. One addition. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
DXA precision and the least significant change for lean mass Started this topic · Outcomes › Body composition · 14 Nov 2025 · 0 likes Posting this under the heading it deserves: DXA precision and the least significant change for lean mass Everything below is what sits behind that. A question about…
Where to report an adverse event officially, by region — a second dataset Replied, post #65 · Safety › Adverse events · 28 Oct 2025 · 3 likes Attribution is genuinely hard for a single case and the reporting schemes are designed to work with that. You are not expected to prove causation to file.
High-resolution MS on aggregates and what it can see Replied, post #89 · Analytics › Mass spectrometry · 10 Oct 2025 · 13 likes High-resolution is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #145 · Data & Tools › Datasets · 11 Sep 2025 · 28 likes Filing a mild objection to the consensus on Aggregated purity results across four. Mild because I might be wrong; an objection because nobody has addressed the case…
What pooling buys you and what it destroys Replied, post #17 · Evidence › Meta-analyses · 7 Sep 2025 · 2 likes Building on post #16 rather than restating it. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality.…
When a preprint is the best available evidence and we say so Replied, post #143 · Evidence › Preprints · 5 Sep 2025 · 5 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
[2026 update] Does dual agonism explain the effect size, or is it dose? Started this topic · Compounds › Tirzepatide · 14 Aug 2025 · 3 likes Asking directly, because I could not find a straight answer: Does dual agonism explain the effect size, or is it dose? A question about dual agonism that I think has a…
Hypertension improvement and when medication needs revisiting Started this topic · Clinical › Comorbidities · 6 Aug 2025 · 41 likes Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Hypertension…
A request that was declined, and the reasoning — a second dataset Replied, post #12 · Documentation › Wiki requests · 6 Aug 2025 · 3 likes This is the first time the answer has come with its own limits attached. Appreciated.
What this community means by "a source", in practical terms Replied, post #59 · Start Here › Welcome · 5 Aug 2025 · 1 like If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #63 · Evidence › Trials · 27 Jun 2025 · 2 likes On post #60 — agreed on the reasoning, with one qualification. Genuine question rather than a rhetorical one: has anyone here actually observed Comparators chosen for…
Repeatability versus intermediate precision Replied, post #42 · Analytics › Method validation · 23 Jun 2025 · 0 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #23 · Practice › Reconstitution · 19 Jun 2025 · 0 likes Where I part company with post #21, and it is a narrow parting. Two people can reconstitute the same vial to different concentrations and both be right. The dose is the…
Coverage for the indication versus for the drug Replied, post #62 · Access › Insurance & coverage · 11 May 2025 · 0 likes Confirming post #59 from a second method, which matters more than confirming it from a second person. Nothing here is legal or medical advice, and appeal processes…
Titles that describe the question, not the situation Replied, post #9 · Start Here › How to Ask · 11 May 2025 · 11 likes Post #7 and I disagree about the size of the effect, not about the direction. Quantities without units are the single commonest reason a question sits unanswered. "Two…
A report I filed that turned out to be wrong, and the correction Replied, post #26 · Sourcing › Vendor reports · 24 Apr 2025 · 18 likes Taking post #25 at face value and following it one step further. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 16 Apr 2025 · 7 likes Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the two are not additive in a simple way when the drugs are combined. The…
Carryover and the ghost peak from last week's standard Replied, post #28 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 1 like Injection volume matters because column overload distorts peak shape, and an overloaded main peak can swallow a small neighbour. A certificate without injection volume…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #13 · Evidence › Journal club · 28 Mar 2025 · 0 likes Where I part company with post #11, and it is a narrow parting. The most useful thing anyone has posted about retatrutide phase 2 obesity paper in this category was a…
Coming back to: An 18-month record including the parts that went badly Replied, post #22 · Outcomes › Progress reports · 1 Mar 2025 · 4 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. Maintenance series are the ones this subcategory needs most and receives least. The…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #46 · Sourcing › Red flags · 31 Jan 2025 · 8 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #81 · Analytics › COA interpretation · 29 Jan 2025 · 10 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #62 · Analytics › COA interpretation · 26 Jan 2025 · 19 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
A claim built entirely on a subgroup analysis — what changed since Replied, post #2 · Evidence › Study critique · 23 Jan 2025 · 0 likes Where a critique rests on a subgroup, check whether the interaction was tested. A difference between subgroups that is not statistically supported is not a difference.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #23 · Compounds › Semaglutide · 11 Jan 2025 · 21 likes I disagree with the framing of published dose-response for semaglutide above, and I think it is a substantive disagreement rather than a terminological one. Setting out…
Follow-up: Individual participant data versus aggregate data Replied, post #15 · Evidence › Meta-analyses · 8 Jan 2025 · 14 likes Post #12 answers the question as asked. The question underneath it is different. Second-hand on Individual participant data versus aggregate, so weight it accordingly —…
Fibre intake when total intake falls, and the constipation link Replied, post #12 · Nutrition & Training › Protein & intake · 31 Dec 2024 · 6 likes No notes. Posting so the count is not one.
Oxidation pathways for methionine and tryptophan Replied, post #5 · Analytics › Impurities & related substances · 25 Dec 2024 · 8 likes A definition problem is doing most of the work in this oxidation pathways for methionine discussion. Once the term is pinned down I suspect the disagreement mostly goes…
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #46 · Sourcing › Regulatory · 4 Dec 2024 · 25 likes Post #45 answers the question as asked. The question underneath it is different. Adding a null result on Research-use-only labelling. I looked, carefully, and found…
Why "any advice?" is the least effective ending for a post Replied, post #42 · Start Here › How to Ask · 16 Nov 2024 · 0 likes Building on post #41 rather than restating it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #6 · Compounds › Semaglutide · 31 Oct 2024 · 21 likes Worth separating two things that post #2 runs together. Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and…
Why I ask for the gradient before I discuss the number Replied, post #29 · Analytics › HPLC & UHPLC · 20 Oct 2024 · 25 likes Retention time is only comparable within a laboratory on a given method. Quoting a retention time across two reports as evidence of identity is not a valid comparison.
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #30 · Wellbeing › Mental health · 14 Oct 2024 · 31 likes Building on post #27 rather than restating it. I would put moderate confidence on the mainstream reading of Food noise and no more. That is not scepticism for its own…
Telehealth prescribing models in the US Replied, post #8 · Regional › North America · 28 Sep 2024 · 0 likes The thing about telehealth prescribing models that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a…
Reporting a discrepancy without making an allegation Replied, post #19 · Sourcing › Vendor reports · 8 Aug 2024 · 20 likes Everything in post #15 holds. The case it does not cover is the one I have. Reporting a discrepancy came up in a thread eighteen months ago and was answered well. I…
Journal club: FLOW and the renal composite, component by component Replied, post #68 · Evidence › Journal club · 15 Jul 2024 · 18 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.